• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

EyePoint, Inc. - Common Stock (NQ:EYPT)

15.91 -2.09 (-11.61%)
Streaming Delayed Price Updated: 2:22 PM EST, Mar 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,758,846
Open 17.98
Bid (Size) 15.89 (100)
Ask (Size) 15.92 (300)
Prev. Close 18.00
Today's Range 15.56 - 17.98
52wk Range 3.910 - 19.11
Shares Outstanding 34,984,044
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
EyePoint (EYPT) Q4 2025 Earnings Call Transcript ↗
March 04, 2026
EyePoint (EYPT) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
EyePoint Inc (NASDAQ:EYPT) Stock Falls on Q4 Earnings and Revenue Miss ↗
March 04, 2026
Via Chartmill

Performance

YTD
-9.0%
-9.0%
1 Month
+19.7%
+19.7%
3 Month
+9.6%
+9.6%
6 Month
+32.6%
+32.6%
1 Year
+161.7%
+161.7%

More News

Read More
News headline image
Retina’s ‘Sustained’ Moment: Ocular Therapeutix Braces for Game-Changing Phase 3 AXPAXLI Data
February 16, 2026
Via MarketMinute
News headline image
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
January 22, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Initial Public Offering
News headline image
Small-Cap Renaissance: Russell 2000 Scales New Heights While Big Tech Stumbles
January 08, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
The Great Rotation: Small Caps Lead the Charge as 2026 Trading Opens
January 02, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
Via Benzinga
News headline image
Earnings Scheduled For August 6, 2025 ↗
August 06, 2025
Via Benzinga
News headline image
Analyst Expectations For EyePoint Pharmaceuticals's Future ↗
May 29, 2025
Via Benzinga
News headline image
Earnings Scheduled For May 7, 2025 ↗
May 07, 2025
Via Benzinga
News headline image
A Peek at EyePoint Pharmaceuticals's Future Earnings ↗
May 06, 2025
Via Benzinga
News headline image
The Small-Cap Renaissance: Why 2026 is the Year of the Russell 2000 and XSU
January 01, 2026
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
The 2026 Horizon: Technical Breakouts Signal a Sustained Bull Run in AI and Energy
December 31, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Demystifying EyePoint Pharmaceuticals: Insights From 4 Analyst Reviews ↗
March 06, 2025
Via Benzinga
News headline image
Is Rapport Therapeutics Stock a Buy After Investment Firm Cormorant Raised Its Stake Over $60 Million? ↗
December 22, 2025
Via The Motley Fool
Topics Regulatory Compliance
News headline image
EyePoint (EYPT) Q3 2025 Earnings Call Transcript ↗
November 05, 2025
Via The Motley Fool
Topics Earnings
News headline image
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) Shares Drop on Q3 Earnings and Revenue Miss ↗
November 05, 2025
Via Chartmill
Topics Earnings
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
October 15, 2025
Via Benzinga
News headline image
EyePoint Pharmaceuticals Raises Capital As It Advances Lead Product To Pivotal Study ↗
October 15, 2025
Via Benzinga
News headline image
EyePoint (EYPT) Q2 Revenue Drops 44% ↗
August 06, 2025
Via The Motley Fool
News headline image
EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) Q2 2025 Earnings Miss Estimates as Shares Drop 4.5% Pre-Market ↗
August 06, 2025
Via Chartmill
Topics Earnings
News headline image
Forecasting The Future: 4 Analyst Projections For EyePoint Pharmaceuticals ↗
June 17, 2025
Via Benzinga
News headline image
Breakout Momentum Plays You May Not Know About
June 06, 2025
Via MarketBeat
News headline image
Heico, Monro, Abercrombie & Fitch, Joby Aviation And Other Big Stocks Moving Higher On Wednesday ↗
May 28, 2025
Via Benzinga
News headline image
Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
March 14, 2025
Via Benzinga

Frequently Asked Questions

Is EyePoint, Inc. - Common Stock publicly traded?
Yes, EyePoint, Inc. - Common Stock is publicly traded.
What exchange does EyePoint, Inc. - Common Stock trade on?
EyePoint, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for EyePoint, Inc. - Common Stock?
The ticker symbol for EyePoint, Inc. - Common Stock is EYPT on the Nasdaq Stock Market
What is the current price of EyePoint, Inc. - Common Stock?
The current price of EyePoint, Inc. - Common Stock is 15.91
When was EyePoint, Inc. - Common Stock last traded?
The last trade of EyePoint, Inc. - Common Stock was at 03/05/26 02:22 PM ET
What is the market capitalization of EyePoint, Inc. - Common Stock?
The market capitalization of EyePoint, Inc. - Common Stock is 556.60M
How many shares of EyePoint, Inc. - Common Stock are outstanding?
EyePoint, Inc. - Common Stock has 557M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap